Goldman Sachs has filed an updated Schedule 13G/A with the SEC, revealing its substantial stake in Definitive Healthcare Corp. This filing, dated November 9, 2026, marks an important moment for the company as it reflects increasing institutional interest in the prepackaged software industry.

Definitive Healthcare Corp., a company focused on providing data and analytics to the healthcare sector, is classified under the SIC code 7372, which pertains to Services-Prepackaged Software. The firm is traded on the Nasdaq under the ticker symbol DH.

According to the filing, Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, beneficially own a combined total of 1,038,392 shares of Definitive Healthcare, representing approximately 1% of the company's Class A common stock. The filing states, "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of changing or influencing the control of the issuer." This statement underscores Goldman Sachs' role as a financial institution rather than an activist investor.

This development may affect various stakeholders, including current shareholders, potential investors, and competitors in the prepackaged software market. With Goldman Sachs' backing, Definitive Healthcare could see increased credibility and potentially more favorable conditions for future growth.

As for what’s next, the filing does not specify any immediate actions or upcoming events related to this stake. However, the increased visibility from such a prominent investor may prompt further interest from other institutional players in the market.